Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

326.03 -3.19 (-0.97%)
Streaming Delayed Price Updated: 10:19 AM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Insulet Announces Appointment of Robert L. Huffines to its Board of Directors
From Insulet Corporation
Via Business Wire
Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years
 
Via Benzinga
Louis Navellier's Growth Strategy Highlights Insulet Corp (NASDAQ:PODD)
Discover how Louis Navellier's growth stock strategy identified Insulet Corp (PODD), a leader in innovative insulin delivery with strong earnings and sales growth. 
Via Chartmill
Insulet to Host Investor Day on November 20, 2025
From Insulet Corporation
Via Business Wire
Price Over Earnings Overview: Insulet
 
Via Benzinga
Discover which S&P500 stocks are making waves on Thursday.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday. 
Via Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks
Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today
Insulet (NASDAQ: PODD) has outperformed the market over the past 15 years by 10.02% on an annualized basis producing an average annual return of 22.35%. Currently, Insulet has a market capitalization... 
Via Benzinga
A Glimpse Into The Expert Outlook On Insulet Through 6 Analysts
6 analysts have shared their evaluations of Insulet (NASDAQ: PODD) during the recent three months, expressing a mix of bullish and bearish perspectives. 
Via Benzinga
Insulet Corp (NASDAQ:PODD): An Affordable Growth Stock with Strong Profitability
Insulet Corp (PODD) exemplifies affordable growth with strong revenue & EPS expansion, high profitability, and a valuation justified by its industry-leading potential. 
Via Chartmill
Align Technology, ResMed, Insulet, Envista, and Dentsply Sirona Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential... 
Via StockStory
Topics World Trade
Here's How Much $100 Invested In Insulet 10 Years Ago Would Be Worth Today
 
Via Benzinga
Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette
From Insulet Corporation
Via Business Wire
Why Insulet (PODD) Shares Are Falling Today
Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) fell 4.3% in the morning session after the company announced a change in its chief financial officer, a move that appeared to... 
Via StockStory
Topics Economy
Tech Stocks Slip, Small Caps Soar Ahead Of Fed Rate Decision: What's Moving Markets Wednesday?
Small-cap and blue-chip stocks advanced in Wednesday morning trading on Wall Street, while technology names lagged and the S&P 500 hovered near record levels as investors braced for the Federal... 
Via Benzinga
Topics Economy
Top S&P500 movers in Wednesday's session
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
Gapping S&P500 stocks in Wednesday's session
Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
Insulet Announces CFO Transition
From Insulet Corporation
Via Business Wire
3 Reasons Investors Love Insulet (PODD)
Insulet has had an impressive run over the past six months as its shares have beaten the S&P 500 by 18%. The stock now trades at $337, marking a 35.7% gain. This was partly thanks to its solid... 
Via StockStory
Topics Stocks
ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading. 
Via StockStory
Topics Economy
Which S&P500 stocks are moving on Wednesday?
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday. 
Via Chartmill
These S&P500 stocks are gapping in today's session
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Wednesday. Discover the gap up and gap down stocks in the S&P500 index. 
Via Chartmill
Insulet Corp (NASDAQ:PODD) Combines Technical Strength and Fundamental Momentum for High-Growth Potential
Insulet Corp (PODD) combines strong technical uptrends with accelerating earnings and revenue growth, making it a top high-growth momentum stock. 
Via Chartmill
3 S&P 500 Stocks to Target This Week
The S&P 500 (^GSPC) is packed with companies that have built dominant market positions, making it a core index for investors. A select few continue to innovate and expand, setting themselves up for... 
Via StockStory
Topics Stocks
Assessing Insulet: Insights From 6 Financial Analysts
 
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
2 Mid-Cap Stocks Worth Your Attention and 1 We Ignore
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
3 Cash-Producing Stocks to Target This Week
Cash-generating companies often have the flexibility to invest, return capital to shareholders, or navigate downturns. The best of these businesses not only accumulate cash but deploy it strategically... 
Via StockStory
Patient Monitoring Stocks Q2 Highlights: Insulet (NASDAQ:PODD)
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers. 
Via StockStory
Topics Artificial Intelligence
Insulet Elevates Eric Benjamin to Chief Operating Officer
From Insulet Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.